642 related articles for article (PubMed ID: 30893071)
1. Procedural Outcomes of Patients With Heart Failure Undergoing Catheter Ablation of Atrial Fibrillation.
Jayanna MB; Mohsen A; Inampudi C; Alvarez P; Giudici MC; Briasoulis A
Am J Ther; 2019; 26(3):e333-e338. PubMed ID: 30893071
[TBL] [Abstract][Full Text] [Related]
2. Catheter ablation of atrial fibrillation in patients with heart failure and preserved ejection fraction.
Black-Maier E; Ren X; Steinberg BA; Green CL; Barnett AS; Rosa NS; Al-Khatib SM; Atwater BD; Daubert JP; Frazier-Mills C; Grant AO; Hegland DD; Jackson KP; Jackson LR; Koontz JI; Lewis RK; Sun AY; Thomas KL; Bahnson TD; Piccini JP
Heart Rhythm; 2018 May; 15(5):651-657. PubMed ID: 29222043
[TBL] [Abstract][Full Text] [Related]
3. Catheter ablation for non-paroxysmal atrial fibrillation accompanied by heart failure with preserved ejection fraction: feasibility and benefits in functions and B-type natriuretic peptide.
Yamauchi R; Morishima I; Okumura K; Kanzaki Y; Morita Y; Takagi K; Nagai H; Watanabe N; Furui K; Yoshioka N; Miyazawa H; Shimojo K; Imaoka T; Sakamoto G; Murohara T
Europace; 2021 Aug; 23(8):1252-1261. PubMed ID: 33693617
[TBL] [Abstract][Full Text] [Related]
4. CHADS2 and CHA2DS2-VASc scores as predictors of left atrial ablation outcomes for paroxysmal atrial fibrillation.
Letsas KP; Efremidis M; Giannopoulos G; Deftereos S; Lioni L; Korantzopoulos P; Vlachos K; Xydonas S; Kossyvakis C; Sideris A
Europace; 2014 Feb; 16(2):202-7. PubMed ID: 23813452
[TBL] [Abstract][Full Text] [Related]
5. Catheter ablation of atrial fibrillation in patients with heart failure: impact of maintaining sinus rhythm on heart failure status and long-term rates of stroke and death.
Ullah W; Ling LH; Prabhu S; Lee G; Kistler P; Finlay MC; Earley MJ; Sporton S; Bashir Y; Betts TR; Rajappan K; Thomas G; Duncan E; Staniforth A; Mann I; Chow A; Lambiase P; Schilling RJ; Hunter RJ
Europace; 2016 May; 18(5):679-86. PubMed ID: 26843584
[TBL] [Abstract][Full Text] [Related]
6. Comparison of CHADS2, R2CHADS2, and CHA2DS2-VASc scores for the prediction of rhythm outcomes after catheter ablation of atrial fibrillation: the Leipzig Heart Center AF Ablation Registry.
Kornej J; Hindricks G; Kosiuk J; Arya A; Sommer P; Husser D; Rolf S; Richter S; Huo Y; Piorkowski C; Bollmann A
Circ Arrhythm Electrophysiol; 2014 Apr; 7(2):281-7. PubMed ID: 24610790
[TBL] [Abstract][Full Text] [Related]
7. The impact of risk score (CHADS2 versus CHA2DS2-VASc) on long-term outcomes after atrial fibrillation ablation.
Jacobs V; May HT; Bair TL; Crandall BG; Cutler M; Day JD; Weiss JP; Osborn JS; Muhlestein JB; Anderson JL; Mallender C; Bunch TJ
Heart Rhythm; 2015 Apr; 12(4):681-6. PubMed ID: 25546809
[TBL] [Abstract][Full Text] [Related]
8. Incidence and risk factors for symptomatic heart failure after catheter ablation of atrial fibrillation and atrial flutter.
Huang HD; Waks JW; Contreras-Valdes FM; Haffajee C; Buxton AE; Josephson ME
Europace; 2016 Apr; 18(4):521-30. PubMed ID: 26311563
[TBL] [Abstract][Full Text] [Related]
9. Conduction recovery following catheter ablation in patients with recurrent atrial fibrillation and heart failure.
Anselmino M; Matta M; Bunch TJ; Fiala M; Scaglione M; Nölker G; Qian P; Neumann T; Ferraris F; Gaita F
Int J Cardiol; 2017 Aug; 240():240-245. PubMed ID: 28258848
[TBL] [Abstract][Full Text] [Related]
10. Catheter ablation of atrial fibrillation in patients with heart failure with reduced ejection fraction: Real world experience from six European centers.
Providência R; de Asmundis C; Chun J; Chierchia G; Defaye P; Anselme F; Creta A; Lambiase PD; Schmidt B; Chen S; Hunter RJ; Combes S; Honarbakhsh S; Combes N; Sousa MJ; Jebberi Z; Albenque JP; Boveda S
J Cardiovasc Electrophysiol; 2019 Aug; 30(8):1270-1277. PubMed ID: 31190350
[TBL] [Abstract][Full Text] [Related]
11. Catheter ablation of atrial fibrillation reduces heart failure rehospitalization in patients with heart failure with preserved ejection fraction.
Fukui A; Tanino T; Yamaguchi T; Hirota K; Saito S; Okada N; Akioka H; Shinohara T; Yufu K; Takahashi N
J Cardiovasc Electrophysiol; 2020 Mar; 31(3):682-688. PubMed ID: 31985099
[TBL] [Abstract][Full Text] [Related]
12. Predictors of arrhythmia recurrence in patients with heart failure undergoing left atrial ablation for atrial fibrillation.
Bazoukis G; Letsas KP; Tse G; Naka KK; Korantzopoulos P; Ntzani E; Vlachos K; Saplaouras A; Pagkalidou E; Michalis LK; Sideris A; Efremidis M
Clin Cardiol; 2018 Jan; 41(1):63-67. PubMed ID: 29356016
[TBL] [Abstract][Full Text] [Related]
13. Atrial Fibrillation Ablation Outcomes and Heart Failure (from the Kansai Plus Atrial Fibrillation Registry).
Tanaka N; Inoue K; Kobori A; Kaitani K; Morimoto T; Kurotobi T; Morishima I; Yamaji H; Matsui Y; Nakazawa Y; Kusano K; Tanaka K; Hirao Y; Okada M; Koyama Y; Okamura A; Iwakura K; Fujii K; Kimura T; Shizuta S;
Am J Cardiol; 2023 Feb; 189():108-118. PubMed ID: 36525835
[TBL] [Abstract][Full Text] [Related]
14. Catheter Ablation for Atrial Fibrillation in Patients With Concurrent Heart Failure.
Arora S; Jaswaney R; Jani C; Zuzek Z; Thakkar S; Patel HP; Patel M; Patel N; Tripathi B; Lahewala S; Arora N; Josephson R; Osman MN; Hoit BD; Kowlgi G; Mulpuru SK; DeSimone CV; Viles-Gonzalez J; Deshmukh A
Am J Cardiol; 2020 Dec; 137():45-54. PubMed ID: 33002464
[TBL] [Abstract][Full Text] [Related]
15. Efficacy, safety, and outcomes of catheter ablation of atrial fibrillation in patients with heart failure with preserved ejection fraction.
Machino-Ohtsuka T; Seo Y; Ishizu T; Sugano A; Atsumi A; Yamamoto M; Kawamura R; Machino T; Kuroki K; Yamasaki H; Igarashi M; Sekiguchi Y; Aonuma K
J Am Coll Cardiol; 2013 Nov; 62(20):1857-65. PubMed ID: 23916940
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Outcomes After Ablation of Atrial Fibrillation in Patients With Heart Failure With Preserved Versus Reduced Ejection Fraction.
Aldaas OM; Malladi CL; Mylavarapu PS; Lupercio F; Darden D; Han FT; Hoffmayer KS; Krummen D; Ho G; Raissi F; Feld GK; Hsu JC
Am J Cardiol; 2020 Dec; 136():62-70. PubMed ID: 32941815
[TBL] [Abstract][Full Text] [Related]
17. Characterising the difference in electrophysiological substrate and outcomes between heart failure and non-heart failure patients with persistent atrial fibrillation.
Haldar SK; Jones DG; Khan H; Panikker S; Jarman JWE; Butcher C; Lim E; Wynn G; Gupta D; Hussain W; Markides V; Wong T
Europace; 2018 Mar; 20(3):451-458. PubMed ID: 28108547
[TBL] [Abstract][Full Text] [Related]
18. Cryoballoon Ablation for the Treatment of Atrial Fibrillation in Patients With Concomitant Heart Failure and Either Reduced or Preserved Left Ventricular Ejection Fraction: Results From the Cryo AF Global Registry.
Rordorf R; Scazzuso F; Chun KRJ; Khelae SK; Kueffer FJ; Braegelmann KM; Okumura K; Al-Kandari F; On YK; Földesi C;
J Am Heart Assoc; 2021 Dec; 10(24):e021323. PubMed ID: 34889108
[TBL] [Abstract][Full Text] [Related]
19. Impact of catheter ablation of atrial fibrillation on long-term clinical outcomes in patients with heart failure.
Ichijo S; Miyazaki S; Kusa S; Nakamura H; Hachiya H; Kajiyama T; Iesaka Y
J Cardiol; 2018 Sep; 72(3):240-246. PubMed ID: 29609877
[TBL] [Abstract][Full Text] [Related]
20. Catheter ablation for patients with atrial fibrillation and heart failure with reduced and preserved ejection fraction: insights from the KiCS-AF multicentre cohort study.
Shiraishi Y; Kohsaka S; Ikemura N; Kimura T; Katsumata Y; Tanimoto K; Suzuki M; Ueda I; Fukuda K; Takatsuki S
Europace; 2023 Feb; 25(1):83-91. PubMed ID: 35851807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
